Jaina Razbek | Epidemiology | Best Scholar Award

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022

Mingtao Liu | Genetic Epidemiology | Best Researcher Award

Dr. Mingtao Liu | Genetic Epidemiology | Best Researcher Award

First Affiliated Hospital of Guangzhou Medical University, Guangzhou | China

Author Profile

Scopus

Orcid ID

Google Scholar

🧬 Mingtao Liu: Emerging Innovator in Respiratory Medicine and Immunity Research 🧬

EARLY ACADEMIC PURSUITS 📚

Mingtao Liu began his academic journey with a B.Sc. in Forensic Science at Guangdong Medical University (2016–2021). During these years, he developed a foundation in analytical skills and scientific investigation, which later fueled his passion for medical research. Following his undergraduate studies, he pursued an M.Sc. in Clinical Laboratory Diagnostics at Guangzhou Medical University (2021–2024), where he focused on laboratory techniques essential to clinical medicine. This period not only honed his skills in diagnostics but also set the stage for his Ph.D. studies in Respiratory Medicine, emphasizing clinical applications and research into respiratory health.

PROFESSIONAL ENDEAVORS 🏆

Currently a Ph.D. candidate at Guangzhou Medical University, Mingtao specializes in respiratory medicine, with his research spanning diagnostic and prognostic biomarkers, particularly in allergic immunity. His work in multi-omics approaches to studying lung inflammation and tumor effects showcases his commitment to unraveling the molecular complexities of respiratory diseases. Mingtao’s technical skills in machine learning, data analysis, and programming languages such as Matlab and Python have empowered him to engage in cutting-edge research, particularly in big data mining and epidemiological investigation.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC EPIDEMIOLOGY🔍

Mingtao’s research contributions are centered on:

  1. Respiratory Immunity: He investigates diagnostic and prognostic biomarkers of respiratory immunity, focusing on allergic responses, a critical area in respiratory health.
  2. Multi-Omics Analysis: His work integrates genomics, proteomics, and metabolomics to explore mechanisms of lung inflammation and tumor development.
  3. LDT and IVD Kits: Mingtao is involved in the development of laboratory-developed tests (LDT) and in vitro diagnostic (IVD) kits based on liquid chromatography–mass spectrometry (LC-MS), providing innovative solutions for clinical diagnostics.
  4. Big Data and Epidemiology: Through epidemiological research and data mining, he is advancing our understanding of respiratory disease prevalence and risk factors.

IMPACT AND INFLUENCE 🌐

Mingtao Liu’s work has garnered recognition for its relevance and potential impact on public health. He has received notable accolades, including the European Respiratory Society 2023 Excellent Young Paper Scholarship, the National Scholarship (2023), and the Outstanding Graduate Scholarship (2024). His research contributes significantly to the development of diagnostic tools and methodologies that can potentially reshape how respiratory diseases are detected and managed, especially in the area of allergic immunity.

ACADEMIC CITES 📈

As a young researcher, Mingtao has begun building his academic footprint. His contributions are starting to be cited in relevant fields, particularly those related to respiratory medicine, allergy research, and clinical diagnostics. This early recognition in academic circles signals his growing influence as a researcher.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Mingtao Liu’s research focus aligns with global health priorities, positioning him to make lasting contributions to the fields of respiratory health and immunology. His work on biomarkers and diagnostic kits is paving the way for more accurate, accessible, and individualized approaches to respiratory healthcare. Looking ahead, Mingtao aspires to continue his research and potentially expand into translational medicine, applying his findings to develop practical healthcare solutions that benefit patients worldwide.

ADDITIONAL TOPICS 📝

  • TECHNICAL PROFICIENCY: Mingtao possesses advanced skills in machine learning, data analysis, and programming (Python, Matlab), as well as fluency in English, Chinese, and Cantonese. These competencies enhance his ability to engage in complex research and communicate his findings to a broad audience.
  • AWARDS AND RECOGNITION: Mingtao’s scholarship awards affirm his dedication to excellence in research and academics. The European Respiratory Society award, in particular, highlights his promise as a leading voice in respiratory medicine.

NOTABLE PUBLICATIONS 📑

"Novel prediction model of early screening lung adenocarcinoma with pulmonary fibrosis based on haematological index

  • Authors: Li, H. , Fu, X. , Liu, M. , Cheng, Z.J. , Sun, B.
  • Journal: BMC Cancer
  • Year: 2024

"Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia

  • Authors: Cheng, Z.J. , Li, H. , Liu, M. , Gan, H. , Sun, B.
  • Journal: BMC Cancer
  • Year: 2024

"Interpreting epidemiologic distribution of total and specific IgE levels for food allergy in Southern China from 2004 to 2023: understanding the mechanisms and focusing on prevention

  • Authors: Liu, M. , Liu, L. , Qi, W. , Huang, H. , Sun, B.
  • Journal: BMC public health
  • Year: 2024

"Decoding acute myocarditis in patients with COVID-19: Early detection through machine learning and hematological indices

  • Authors: Li, H. , Cheng, Z.J. , Fu, X. , Wang, F. , Sun, B.
  • Journal: iScience
  • Year: 2014

"A Pilot HRCT Follow-Up Study to Test the Feasibility of Predictive Efficacy of Serum Periostin in Idiopathic Pulmonary Fibrosis

  • Authors: Liu, M. , Cheng, Z.J. , Chen, J. , Huang, H. , Sun, B.
  • Journal: Journal of Inflammation Research
  • Year: 2024